In patients with Alzheimer’s disease, increased serum TNF-α levels were found to be associated with an increased rate of cognitive decline.49 When TNF-α signalling is inhibited both in patients with Alzheimer’s disease and in transgenic mouse models, Alzheimer’s pathology is attenuated and cognition improves. Here, TNF is linked to early-onset autosomal dominant Alzheimer disease.